Bioventus Grows Sales Significantly in Q3, 2024

By Tracey RomeroDecember 27, 2024 1 min read Premium comments

Source: Bioventus Inc. and AdobeStock

Premium#bioventus#3q24earnings

Bioventus Inc. reported $138.964 million in sales and $4.074 million in operating profit for the quarter ending September 30, 2024, which met both Wall Street’s expectations and management’s guidance.

Join 13,000+ Subscribers

Get unlimited access to OTW reporting, member discussions, and the weekly newsletter.

13,000+ subscribers

Every OTW article, fully unlocked
Member comments and discussion
The weekly orthopedic business briefing

React: